secwatch.observer — SEC 8-K summary
======================================

Issuer:     SS Innovations International, Inc. (SSII)
CIK:        0001676163
Form:       8-K
Filed at:   2025-04-24T23:59:59+00:00
Accession:  0001213900-25-034814
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SS Innovations approved for Nasdaq listing; trading begins April 25 under SSII
------------------------------------------------------------------------------

- Common stock approved for listing on Nasdaq Capital Market; trading begins April 25, 2025 under symbol SSII.
- Installed 80 SSi Mantra systems in 75 hospitals; performed 3,500+ surgeries including 195 robotic cardiac surgeries with zero device-related mortality.
- Received CDSCO approval for telesurgery/tele-proctoring; performed 16 telesurgeries including world's first robotic cardiac telesurgery up to 1,200 miles.
- FY2024 revenue $20.6M (+251% YoY); gross margin 40.9% (up from 12.3% in 2023).
- Pursuing EU CE Mark (late 2025) and U.S. FDA approval (early 2026) for SSi Mantra system.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676163/000121390025034814/0001213900-25-034814-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676163/000121390025034814/ea0239340-8k_ssinnov.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-034814

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer